Atrial fibrillation: new oral anticoagulants in the „real world“ (short version)
What is the matter with the Cochrane board?
THERAPY FROM A CRITICAL VIEWPOINT
New European hypertension guideline: classification, treatment initiation, target values
a-t READERS QUESTIONS AND COMMENTS
Pneumonia with proton pump inhibitors?
Nitrosamine contaminated sartanes – batches of losartan and irbesartan also affected
Primary prevention with acetylsalicylic acid – new findings?
KIJIMEA REIZDARM against irritable bowel syndrome?
Increased skin cancer risk with hydrochlorothiazide – what are the consequences?
Further restrictions of use of gyrase inhibitors
Increased risk of PARKINSONs disease with methylphenidate (RITALIN, Generics)
CURRENT ADR NETWORK REPORT
Intrauterine devices: caution – risk of breakage free article
e a-t ON THE INTERNET
Atrial fibrillation: new oral anticoagulants in the „real world“ (long version)
© 2018 arznei-telegramm